Results showed that female patients with high PMCA4 transcript levels had a significantly longer progression-free survival, and that high transcript levels derived from RNA-seq of cutaneous melanoma were associated with a significantly longer overall survival and improved prognosis after PD-1 blockade [40]. This evidence concerns the gene ATP2B4 and cutaneous melanoma.